What is the official website of Fresenius Kabi USA ?

The official website of Fresenius Kabi USA is http://www.fresenius-kabi.com/us.

What is Fresenius Kabi USA's cybersecurity risk score?

Fresenius Kabi USA has an AI-generated cybersecurity risk score of 761 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Fresenius Kabi USA experienced?

According to Rankiteo, Fresenius Kabi USA currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Fresenius Kabi USA been affected by any supply chain cyber incidents ?

According to Rankiteo, Fresenius Kabi USA has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Fresenius Kabi USA have SOC 2 Type 1 certification ?

According to Rankiteo, Fresenius Kabi USA is not certified under SOC 2 Type 1.

Does Fresenius Kabi USA have SOC 2 Type 2 certification ?

According to Rankiteo, Fresenius Kabi USA does not hold a SOC 2 Type 2 certification.

Does Fresenius Kabi USA comply with GDPR ?

According to Rankiteo, Fresenius Kabi USA is not listed as GDPR compliant.

Does Fresenius Kabi USA have PCI DSS certification ?

According to Rankiteo, Fresenius Kabi USA does not currently maintain PCI DSS compliance.

Does Fresenius Kabi USA comply with HIPAA ?

According to Rankiteo, Fresenius Kabi USA is not compliant with HIPAA regulations.

Does Fresenius Kabi USA have ISO 27001 certification ?

According to Rankiteo,Fresenius Kabi USA is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Fresenius Kabi USA operate in ?

Fresenius Kabi USA operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Fresenius Kabi USA have ?

Fresenius Kabi USA employs approximately 1,723 people worldwide.

Does Fresenius Kabi USA own any subsidiaries ?

Fresenius Kabi USA presently has no subsidiaries across any sectors.

How many LinkedIn followers does Fresenius Kabi USA have ?

Fresenius Kabi USA's official LinkedIn profile has approximately 55,677 followers.

What is the NAICS classification code for Fresenius Kabi USA ?

Fresenius Kabi USA is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Fresenius Kabi USA have a Crunchbase profile ?

No, Fresenius Kabi USA does not have a profile on Crunchbase.

Does Fresenius Kabi USA have a LinkedIn profile ?

Yes, Fresenius Kabi USA maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/fresenius-kabi-usa.

How many cybersecurity incidents has Fresenius Kabi USA experienced ?

As of June 3, 2026, Rankiteo reports that Fresenius Kabi USA has experienced 2 cybersecurity incidents.

How many peer or competitor companies does Fresenius Kabi USA have ?

Fresenius Kabi USA has an estimated 5,671 peer or competitor companies worldwide.

What types of cybersecurity incidents has Fresenius Kabi USA faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Ransomware.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

FKU

Boost Score +25 with badge (5 left)

761

/1000

Fair

786

/1000

Fair

Fresenius Kabi USA Vendor Cyber Rating & Cyber Score

fresenius-kabi.com

Add Your Compliance Badge

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With more than 43,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices,

FKU A.I CyberSecurity Scoring

Scoring History

FKU

Fresenius Kabi USA CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Fresenius Group

Ransomware

100

5/2020

FRE1770566194

Fresenius Kabi USA

Ransomware

05/2020

FRE2038291222

Loading…

A.I.

FKU Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for FKU

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Fresenius Kabi USA in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Fresenius Kabi USA in 2026.

Incident Types FKU vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Fresenius Kabi USA in 2026.

Incident History - FKU (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Fresenius Kabi USA Subsidiaries

FKU

Pharmaceutical Manufacturing

Website: http://www.fresenius-kabi.com/us

Company Size: 1,723

Fresenius KabiPharmaceutical Manufacturing

Fresenius GroupHospitals and Health Care

Fresenius Digital TechnologyInformation Technology & Services

Helios Health GmbHHospitals and Health Care

QuirónsaludWellness and Fitness Services

Helios Kliniken GmbHHospitals and Health Care

Fresenius Investor RelationsKrankenhäuser und Gesundheitseinrichtungen

Fresenius Kabi BrasilPharmaceutical Manufacturing

Fresenius Kabi FrancePharmaceutical Manufacturing

Fresenius Kabi UKPharmaceutical Manufacturing

MOTIV eLearningHospitals and Health Care

Fenwal, Inc., a Fresenius Kabi CompanyMedical Equipment Manufacturing

Fresenius Kabi CanadaPharmaceutical Manufacturing

Fresenius Kabi Asia PacificPharmaceutical Manufacturing

Fresenius Kabi ColombiaPharmaceutical Manufacturing

Fresenius Kabi ArgentinaPharmaceutical Manufacturing

Fresenius Kabi Business ServicesAccounting

Fresenius Kabi PolskaPharmaceutical Manufacturing

Fresenius Kabi ChilePharmaceutical Manufacturing

Fresenius Kabi DanmarkPharmaceutical Manufacturing

Fresenius Kabi South AfricaPharmaceutical Manufacturing

Fresenius Kabi NetherlandsPharmaceutical Manufacturing

Fresenius Kabi IrelandPharmaceutical Manufacturing

Fresenius Kabi Viet Nam Pharmaceutical Manufacturing

Fresenius Kabi BelgiumPharmaceutical Manufacturing

Fresenius Kabi SchweizPharmaceutical Manufacturing

Fresenius Kabi (Singapore) Pte Ltd, SingaporePharmaceutical Manufacturing

Fresenius Kabi Puerto RicoManufacturing

Fresenius Kabi MedTech EuropeMedical Equipment Manufacturing

Fresenius Kabi Australia and New ZealandPharmaceutical Manufacturing

Fresenius Kabi EspañaPharmaceutical Manufacturing

Fresenius Kabi AustriaPharmaceutical Manufacturing

Fresenius Kabi EcuadorPharmaceutical Manufacturing

Fresenius Kabi ItaliaPharmaceutical Manufacturing

Fresenius Kabi EuropePharmaceutical Manufacturing

Fresenius Kabi MéxicoPharmaceutical Manufacturing

Unidos por la Nutrición Clínica MéxicoHospitals and Health Care

Loading…

Fresenius Kabi USA Similar Companies

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

MENARINI Group

menarini.com

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 609 million packets of product a year and distribute them to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Loading…

NEWS

Fresenius Kabi USA CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

February 09, 2026 08:00 AM

Fresenius Kabi and Phlow Corp. Announce First-Ever, End-to-End, U.S. Manufacturing Collaboration for Epinephrine Injection, USP

LAKE ZURICH, Ill. & RICHMOND, Va., February 09, 2026--Fresenius Kabi and Phlow Corp. announced today a first-of-its-kind collaboration to...

Read Article

January 20, 2026 08:00 AM

Fresenius Kabi Recognized as a Top Employer in the United States for the Fourth Consecutive Year

LAKE ZURICH, Ill., January 20, 2026--Fresenius Kabi, part of the healthcare company Fresenius, and a leading provider of essential medicines...

Read Article

November 24, 2025 08:00 AM

Fresenius Kabi Introduces Dalbavancin for Injection (for single-dose regimen use only)

LAKE ZURICH, Ill., November 24, 2025--Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential...

Read Article

November 09, 2025 08:00 AM

Hospital Acid Reflux Drug Recalled: Endotoxins Risk Sepsis, Shock

Fresenius Kabi recalls 3 lots of hospital Famotidine Injection (20 mg/2 mL) shipped Jan–May 2025 over endotoxin levels.

Read Article

July 17, 2025 07:00 AM

Fresenius Kabi Receives 2025 Premier Supplier Legacy Award

LAKE ZURICH, Ill., July 17, 2025--Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential...

Read Article

March 05, 2025 08:00 AM

Update on Alert: Infusion Pump Software Issue from Fresenius Kabi USA

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program.

Read Article

December 12, 2024 08:00 AM

FDA Warns About Failure Risks with Fresenius Ivenix Infusion Pumps

An alert has been issued about problems with Fresenius Ivenix Infusion pumps, due to a risk that the devices may fail to deliver life-saving...

Read Article

October 01, 2024 07:00 AM

Infusion Pump Software Correction: Fresenius Kabi Corrects Ivenix LVP

Ivenix LVP allows for controlled administration of large volumes of fluids but software anomalies may lead to delay or underdosing of...

Read Article

May 25, 2023 07:00 AM

Fresenius lifts 2023 outlook for hospital drugs unit Kabi

German healthcare group Fresenius SE lifted its earnings target for generic hospital drugs unit Kabi, citing demand for blood plasma...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-44654

SUMMARY

LibreChat is an enhanced ChatGPT clone that supports multiple AI providers. In versions up to and including 0.8.3, a shared-agent editor can delete file records through `DELETE /api/files` that the owner has reused across multiple agents. The deletion removes the file globally — not just from the shared agent — breaking the owner's other private agents that reference the same `file_id`. The private agent retains a stale `file_id` reference that no longer resolves. A shared-agent editor can destroy files that the owner uses across multiple agents. The owner's private agents — which the attacker has no access to — break silently with stale `file_id` references. This is a cross-agent integrity violation: editing access to one agent should not affect another. Version 0.8.4 contains a patch.

Published

Date2026-06-02

Updated

Date2026-06-02

RISK INFORMATION (Score: )

cvss4

Base Score: 5.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:H/VA:H/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://github.com/danny-avila/LibreChat/security/advisories/GHSA-f8jg-v856-mf6q

CVE-2026-44653

SUMMARY

LibreChat is an enhanced ChatGPT clone that supports multiple AI providers. In versions up to and including 0.8.3, users with only `VIEW` access to an MCP server can retrieve the server's decrypted admin-managed secrets through `GET /api/mcp/servers` and `GET /api/mcp/servers/:serverName`. The returned config includes plaintext values for `apiKey.key` and `oauth.client_secret`. This allows viewers of a shared MCP server to exfiltrate the underlying provider credentials. Version 0.8..4 contains a patch. Other remediations include: never returning decrypted admin-managed secrets to non-owners; redacting apiKey.key and oauth.client_secret from all API responses consider returning only boolean presence indicators for secrets, similar to the auth-values route pattern; and, if owners need to edit configs without re-entering secrets, preserving secrets server-side and returning placeholders instead of plaintext.

Published

Date2026-06-02

Updated

Date2026-06-02

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

2.8

REFERENCES

https://github.com/danny-avila/LibreChat/security/advisories/GHSA-6vqg-rgpm-qvf9

CVE-2026-42507

SUMMARY

When returning errors, functions in the net/textproto package would include its input as part of the error. This might allow an attacker to inject misleading content to errors that are printed or logged.

Published

Date2026-06-02

Updated

Date2026-06-02

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-42504

SUMMARY

Decoding a maliciously-crafted MIME header containing many invalid encoded-words can consume excessive CPU.

Published

Date2026-06-02

Updated

Date2026-06-02

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-41412

SUMMARY

alf.io is an open source ticket reservation system for conferences, trade shows, workshops, and meetups. Prior to version 2.0-M5-2606, the alf.io extension sandbox injects a fully-functional HTTP client (`simpleHttpClient`) into every extension script's scope. The `postFileAndSaveResponse()` method accepts an arbitrary filesystem path as its `file` parameter and reads the file contents using `new FileInputStream(file)` with no path validation, directory restriction, or allowlist. A malicious extension script can read any file accessible to the JVM process user and exfiltrate it to an attacker-controlled server via HTTP POST. Version 2.0-M5-2606 patches the issue.

Published

Date2026-06-02

Updated

Date2026-06-02

RISK INFORMATION (Score: 4.9)

cvss3

Base Score: 4.9

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

1.2

REFERENCES

https://github.com/alfio-event/alf.io/security/advisories/GHSA-6m62-53cw-4373

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…